Josamycin (1) is a macrolide antibiotic primarily produced by Streptomyces narbonensis var.Josamyceticus(S. narbonensis) through fermentation. It is widely used to treat respiratory and urinary tract infections.Currently, the domestic supply of the active pharmaceutical ingredient of 1 relies on imports, making it of great significance to explore microbial fermentation for its industrial production. This study performed whole genome sequencing on S.narbonensis J-2-40, conducted functional annotation of its encoded proteins, analyzed and annotated its biosynthetic gene clusters, and speculated the biosynthetic pathway of 1 . The results showed that the total length of the 1 biosynthetic gene cluster sequence is 73 893 bp, containing 38 open reading frames. It exhibited the characteristics of modular type Ⅰpolyketide synthase architecture. The biosynthetic pathway of 1 mainly included polyketide precursor synthesis, polyketide chain elongation, glycosyl side chain assembly, and post-assembly modifications. Based on this, genetic engineering modifications on the 1 producing strain S. narbonensis were investigated by overexpressing acyltransferase genes (orf 9, orf 29) and acetyl-CoA carboxylase gene (accA2BE). Finally, the engineered strains, JOS-ORF29 and JOS-A2BE were successfully constructed, achieving 13% and 31% increases in yield compared to the parental strain, respectively.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |